tiprankstipranks
Advertisement
Advertisement

VALN Stock Latest News

Valneva downgraded to Sell from Neutral at Goldman Sachs
The FlyValneva downgraded to Sell from Neutral at Goldman Sachs
6d ago
VALN
Valneva price target lowered to $11 from $13 at Guggenheim
PremiumThe Fly
Valneva price target lowered to $11 from $13 at Guggenheim
12d ago
VALN
Valneva Showcases Chikungunya Vaccine Progress at World Vaccine Congress in Washington
PremiumCompany Announcements
Valneva Showcases Chikungunya Vaccine Progress at World Vaccine Congress in Washington
1M ago
6K
VALN
Valneva and Pfizer Report Strong Phase 3 Efficacy for Lyme Disease Vaccine Candidate
PremiumCompany Announcements
Valneva and Pfizer Report Strong Phase 3 Efficacy for Lyme Disease Vaccine Candidate
1M ago
6K
VALN
Jefferies says Valneva stock weakness presents buying opportunity
PremiumThe Fly
Jefferies says Valneva stock weakness presents buying opportunity
1M ago
VALN
Pfizer’s (PFE) Lyme Vaccine Partner Valneva Stock Crashes 38% despite Trial Success
PremiumMarket NewsPfizer’s (PFE) Lyme Vaccine Partner Valneva Stock Crashes 38% despite Trial Success
1M ago
PFE
VALN
Pfizer, Valneva announce ‘positive’ results from Phase 3 VALOR trial
Premium
The Fly
Pfizer, Valneva announce ‘positive’ results from Phase 3 VALOR trial
1M ago
PFE
VALN
Valneva Posts 2025 Results, Flags 2026 as Pivotal Year Ahead of Lyme Vaccine Phase 3 Data
Premium
Company Announcements
Valneva Posts 2025 Results, Flags 2026 as Pivotal Year Ahead of Lyme Vaccine Phase 3 Data
1M ago
6K
VALN
Elaris FlexCo secures exclusive global license from Valneva
PremiumThe Fly
Elaris FlexCo secures exclusive global license from Valneva
1M ago
VALN
VALN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
VALN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
VALN
Valneva Sets March 18 Date to Release Full-Year 2025 Results
PremiumCompany Announcements
Valneva Sets March 18 Date to Release Full-Year 2025 Results
2M ago
6K
VALN
Valneva Ramps Up Investor Outreach Ahead of Key Lyme Vaccine Data
PremiumCompany Announcements
Valneva Ramps Up Investor Outreach Ahead of Key Lyme Vaccine Data
2M ago
6K
VALN
Valneva Posts Stable 2025 Revenue, Sets 2026 Outlook Ahead of Key Lyme Vaccine Data
PremiumCompany AnnouncementsValneva Posts Stable 2025 Revenue, Sets 2026 Outlook Ahead of Key Lyme Vaccine Data
2M ago
6K
VALN
Valneva’s IXCHIQ Chikungunya Vaccine Faces New UK Use Restrictions but Retains Positive Benefit–Risk Profile
Premium
Company Announcements
Valneva’s IXCHIQ Chikungunya Vaccine Faces New UK Use Restrictions but Retains Positive Benefit–Risk Profile
2M ago
6K
VALN
Valneva and Instituto Butantan Launch Pilot Chikungunya Vaccination Campaign in Brazil
Premium
Company Announcements
Valneva and Instituto Butantan Launch Pilot Chikungunya Vaccination Campaign in Brazil
3M ago
6K
VALN
Valneva Withdraws U.S. IXCHIQ Chikungunya Filings After FDA Clinical Hold
PremiumCompany Announcements
Valneva Withdraws U.S. IXCHIQ Chikungunya Filings After FDA Clinical Hold
3M ago
6K
VALN
Valneva withdraws BLA, IND application for Ixchiq in U.S.
PremiumThe Fly
Valneva withdraws BLA, IND application for Ixchiq in U.S.
3M ago
VALN
Valneva to Engage Investors at J.P. Morgan Conference Ahead of Key Lyme Vaccine Data
PremiumCompany Announcements
Valneva to Engage Investors at J.P. Morgan Conference Ahead of Key Lyme Vaccine Data
4M ago
6K
VALN
Valneva Regains Full Rights to Chikungunya Vaccine as Serum Institute License Ends
PremiumCompany Announcements
Valneva Regains Full Rights to Chikungunya Vaccine as Serum Institute License Ends
4M ago
6K
VALN
Valneva, Serum Institute of India discontinue chikungunya vaccine pact
PremiumThe FlyValneva, Serum Institute of India discontinue chikungunya vaccine pact
4M ago
VALN
Valneva Reports Positive Phase 2 Results for Chikungunya Vaccine in Children
Premium
Company Announcements
Valneva Reports Positive Phase 2 Results for Chikungunya Vaccine in Children
5M ago
6K
VALN
Valneva reports ‘positive’ final Phase 2 results for chikungunya vaccine
Premium
The Fly
Valneva reports ‘positive’ final Phase 2 results for chikungunya vaccine
5M ago
VALN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >